Skip to main content
Log in

Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT study: reply to comment by Erro et al.

  • Letter to the Editor
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Erro R, Pappatà S, Barone P, Pellecchia MT. Comment on Di Giuda et al.: Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study. Eur J Nucl Med Mol Imaging. doi:10.1007/s00259-012-2300-z.

  2. Di Giuda D, Camardese G, Bentivoglio AR, Cocciolillo F, Guidubaldi A, Pucci L, et al. Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study. Eur J Nucl Med Mol Imaging. 2012;39:1937–48. doi:10.1007/s00259-012-2232-7.

    Article  PubMed  CAS  Google Scholar 

  3. Weintraub D, Newberg AB, Cary MS, Siderowf AD, Moberg PJ, Kleiner-Fisman G, et al. Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson’s disease. J Nucl Med. 2005;46:227–32.

    PubMed  CAS  Google Scholar 

  4. Rektorova I, Srovnalova H, Kubikova R, Prasek J. Striatal dopamine transporter imaging correlates with depressive symptoms and tower of London task performance in Parkinson’s disease. Mov Disord. 2008;23:1580–7.

    Article  PubMed  Google Scholar 

  5. Müller U, Wächter T, Barthel H, Reuter M, von Cramon DY. Striatal [123I]beta-CIT SPECT and prefrontal cognitive functions in Parkinson’s disease. J Neural Transm. 2000;107(3):303–19.

    Article  PubMed  Google Scholar 

  6. Burn DJ, Landau S, Hindle JV, Samuel M, Wilson KC, Hurt CS, et al.; PROMS-PD study group. Parkinson’s disease motor subtypes and mood. Mov Disord. 2012;27(3):379–86. doi:10.1002/mds.24041.

    Article  PubMed  Google Scholar 

  7. Leentjens AF, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE, et al. Anxiety rating scales in Parkinson’s disease: critique and recommendations. Mov Disord. 2008;23(14):2015–25.

    Article  PubMed  Google Scholar 

  8. Leentjens AF, Dujardin K, Marsh L, Richard IH, Starkstein SE, Martinez-Martin P. Anxiety rating scales in Parkinson’s disease: a validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale. Mov Disord. 2011;26(3):407–15. doi:10.1002/mds.23184.

    Article  PubMed  Google Scholar 

  9. Schrag A, Barone P, Brown RG, Leentjens AF, McDonald WM, Starkstein S, et al. Depression rating scales in Parkinson’s disease: critique and recommendations. Mov Disord. 2007;22(8):1077–92.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniela Di Giuda.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Di Giuda, D., Camardese, G., Cocciolillo, F. et al. Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT study: reply to comment by Erro et al.. Eur J Nucl Med Mol Imaging 40, 638–639 (2013). https://doi.org/10.1007/s00259-012-2303-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-012-2303-9

Keywords

Navigation